331 related articles for article (PubMed ID: 16005196)
1. The effect of powder blend and tablet structure on drug release mechanisms of hydrophobic starch acetate matrix tablets.
van Veen B; Pajander J; Zuurman K; Lappalainen R; Poso A; Frijlink HW; Ketolainen J
Eur J Pharm Biopharm; 2005 Oct; 61(3):149-57. PubMed ID: 16005196
[TBL] [Abstract][Full Text] [Related]
2. Liquid boundary movements in cylindrical and convex hydrophobic matrix tablets: Effects on tablet cracking and drug release.
Pajander J; van Veen B; Korhonen O; Lappalainen R; Ketolainen J
Eur J Pharm Biopharm; 2006 Oct; 64(2):167-72. PubMed ID: 16846722
[TBL] [Abstract][Full Text] [Related]
3. Modifying drug release and tablet properties of starch acetate tablets by dry powder agglomeration.
Mäki R; Suihko E; Rost S; Heiskanen M; Murtomaa M; Lehto VP; Ketolainen J
J Pharm Sci; 2007 Feb; 96(2):438-47. PubMed ID: 17075868
[TBL] [Abstract][Full Text] [Related]
4. Drug release phenomena within a hydrophobic starch acetate matrix: FTIR mapping of tablets after in vitro dissolution testing.
Pajander J; Soikkeli AM; Korhonen O; Forbes RT; Ketolainen J
J Pharm Sci; 2008 Aug; 97(8):3367-78. PubMed ID: 18085712
[TBL] [Abstract][Full Text] [Related]
5. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of novel starch acetate-diltiazem controlled release tablets in healthy human volunteers.
Korhonen O; Kanerva H; Vidgren M; Urtti A; Ketolainen J
J Control Release; 2004 Mar; 95(3):515-20. PubMed ID: 15023462
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound transmission technique as a potential tool for physical evaluation of monolithic matrix tablets.
Hakulinen MA; Pajander J; Leskinen J; Ketolainen J; van Veen B; Niinimäki K; Pirskanen K; Poso A; Lappalainen R
AAPS PharmSciTech; 2008; 9(1):267-73. PubMed ID: 18446491
[TBL] [Abstract][Full Text] [Related]
8. Particle size distribution and evolution in tablet structure during and after compaction.
Fichtner F; Rasmuson A; Alderborn G
Int J Pharm; 2005 Mar; 292(1-2):211-25. PubMed ID: 15725568
[TBL] [Abstract][Full Text] [Related]
9. Effects of physical properties for starch acetate powders on tableting.
Korhonen O; Pohja S; Peltonen S; Suihko E; Vidgren M; Paronen P; Ketolainen J
AAPS PharmSciTech; 2002; 3(4):E34. PubMed ID: 12916928
[TBL] [Abstract][Full Text] [Related]
10. Formulation study and drug release mechanism of a new theophylline sustained-release preparation.
Hayashi T; Kanbe H; Okada M; Suzuki M; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2005 Nov; 304(1-2):91-101. PubMed ID: 16154302
[TBL] [Abstract][Full Text] [Related]
11. Pore size distribution in tablets measured with a morphological sieve.
Wu YS; van Vliet LJ; Frijlink HW; van der Voort Maarschalk K
Int J Pharm; 2007 Sep; 342(1-2):176-83. PubMed ID: 17580106
[TBL] [Abstract][Full Text] [Related]
12. High-amylose sodium carboxymethyl starch matrices for oral, sustained drug-release: formulation aspects and in vitro drug-release evaluation.
Brouillet F; Bataille B; Cartilier L
Int J Pharm; 2008 May; 356(1-2):52-60. PubMed ID: 18280069
[TBL] [Abstract][Full Text] [Related]
13. Drug release behaviour from methyl methacrylate-starch matrix tablets: effect of polymer moisture content.
Bravo-Osuna I; Ferrero C; Jiménez-Castellanos MR
Eur J Pharm Biopharm; 2008 May; 69(1):285-93. PubMed ID: 17997292
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of dissolution characteristics of polymeric and wax granulations of theophylline and their tablets.
Uhumwangho MU; Okor RS
Pak J Pharm Sci; 2008 Jul; 21(3):230-6. PubMed ID: 18614417
[TBL] [Abstract][Full Text] [Related]
15. Dissolution characteristics of cylindrical particles and tablets.
Fukunaka T; Yaegashi Y; Nunoko T; Ito R; Golman B; Shinohara K
Int J Pharm; 2006 Mar; 310(1-2):146-53. PubMed ID: 16414218
[TBL] [Abstract][Full Text] [Related]
16. Optimization of matrix tablets controlled drug release using Elman dynamic neural networks and decision trees.
Petrović J; Ibrić S; Betz G; Đurić Z
Int J Pharm; 2012 May; 428(1-2):57-67. PubMed ID: 22402474
[TBL] [Abstract][Full Text] [Related]
17. Effect of formulation parameters and drug-polymer interactions on drug release from starch acetate matrix tablets.
Pajander J; Korhonen O; Laamanen M; Ryynänen EL; Grimsey I; van Veen B; Ketolainen J
J Pharm Sci; 2009 Oct; 98(10):3676-90. PubMed ID: 19177516
[TBL] [Abstract][Full Text] [Related]
18. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
Cao QR; Choi YW; Cui JH; Lee BJ
J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
[TBL] [Abstract][Full Text] [Related]
19. [Use of mercury porosimetry, assisted by nitrogen adsorption in the investigation of the pore structure of tablets].
Szepes A; Kovács J; Szabóné Revész P
Acta Pharm Hung; 2006; 76(3):119-25. PubMed ID: 17094658
[TBL] [Abstract][Full Text] [Related]
20. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
